Watch Gastric Cancer Summit Day 1 Videos
Main content start
Gastric Cancer Summit 2022
Thursday, November 3
Introductions
Joo Ha Hwang, MD, PhD | Bryant Lin, MD, MSE | Jennifer Soh
Session 1: Gastric Cancer Epidemiology and Modeling
Approaches to Modeling Gastric Cancer in the United States
Chin Hur, MD, Columbia University

Cost Effectiveness of Gastric Cancer Screening and Prevention
Shailja Shah, MD, UCSD/San Diego VA

Ethnic and racial differences in gastric cancer incidence in the US
Eunjung Lee, PhD, University of Southern California

Developing predictive tools for gastric cancer screening
Haejin In, MD, Rutgers University

Gastric Cancer Epidemiology and Modeling Panel: Question and Answer
Session 2: Gastric Cancer as a Critical Healthcare Disparity
Should we be Screening at Risk Groups for H. pylori?
Meira Epplein, PhD, Duke University

Gastric Cancer among Asian Americans
Yanghee Woo, MD, City of Hope

Keynote Address: Finding our Path Forward for Gastric Cancer Control - Lessons from the Field
Karen Kim, MD, University of Chicago

Gastric Cancer as a Critical Healthcare Disparity Panel: Question and Answer
Session 3: From Advocacy to Policy
Virtual Address by Representative Judy Chu
US Congresswoman Judy Chu, 27th District of California

Keynote Address: Health Policy and Health Equity for AANHPI Populations
Howard Koh, MD, MPH, Harvard University

The role of the USPSTF in advancing preventative care in the United States
Doug Owens, MD, Stanford University

Developing Lung Cancer Screening Guidelines
Edward S. Kim, MD, City of Hope

Advocacy for Gastric Cancer
Aki Smith, Hope for Stomach Cancer

From Advocacy to Policy Panel: Question and Answer
Session 4: Role of Professional Societies and Funders in Advancing Gastric Cancer Research and Policy
Societal Guidelines: Lessons learned from Barrett’s Esophagus
John Inadomi, MD, University of Utah Health

Developing Guidelines for Gastric Intestinal Metaplasia
Douglas Morgan, MD, University of Alabama at Birmingham

NCI Efforts in Gastric Cancer Prevention
Matthew Young, PhD, National Cancer Institute
